Institute for Biomedical Ethics, University of Basel, Missionsstrasse 24, CH-4055 Basel, Basel-Stadt, Switzerland.
J Med Ethics. 2012 Oct;38(10):605-8. doi: 10.1136/medethics-2012-100616. Epub 2012 Aug 11.
In their recent paper in this journal, Heinz and colleagues accuse proponents of cognitive enhancement of making two unjustified assumptions. The first of these is the assumption that neuroenhancing drugs will be safe; the second is that research into cognitive enhancement does not pose particular ethical problems. Heinz and colleagues argue that both these assumptions are false. Here, I argue that these assumptions are in fact correct, and that Heinz and colleagues themselves make several assumptions that undermine their argument. Neuroenhancement does raise several ethical concerns, but safety and research in this area pose no unique difficulties.
在他们最近发表在该期刊上的论文中，Heinz 及其同事指责认知增强的支持者做出了两个毫无根据的假设。其中之一是假设神经增强药物将是安全的；另一个假设是对认知增强的研究不会带来特殊的伦理问题。Heinz 及其同事认为这两个假设都是错误的。在这里，我认为这些假设实际上是正确的，而且 Heinz 及其同事自己也做出了一些假设，这些假设削弱了他们的论点。神经增强确实引发了一些伦理问题，但在这一领域的安全性和研究并没有带来独特的困难。
